XML 14 R18.htm IDEA: XBRL DOCUMENT v3.19.3
Employee Equity-Based Compensation
9 Months Ended
Sep. 30, 2019
Share-based Payment Arrangement [Abstract]  
Employee Equity-Based Compensation
NOTE 12. EMPLOYEE EQUITY-BASED COMPENSATION

The following table summarizes option activity under all plans during the nine months ended September 30, 2019:

 
Number of Shares
Weighted Average Exercise Price per Share
Options Outstanding January 1, 2019
8,090,636

$
12.22

Granted
2,883,596

14.47

Forfeited
(420,098
)
20.74

Exercised
(327,215
)
14.91

Expired
(67,574
)
23.41

Options Outstanding September 30, 2019
10,159,345

$
12.34



The table below summarizes the resulting weighted average inputs used to calculate the estimated fair value of options awarded during the periods shown below:

 
Three Months Ended
 
September 30,
September 30,
 
2019
2018
Expected term (in years)
6.46

5.53

Volatility
59
%
58
%
Expected dividends


Risk free interest rates
1.47
%
2.75
%
Weighted average fair value
$
9.66

$
11.48



The following table shows summary information for outstanding options and options that are exercisable (vested) as of September 30, 2019:

 
Options
Outstanding
Options
Exercisable
Number of options
10,159,345

6,137,856

Weighted average remaining contractual term (in years)
6.14

4.32

Weighted average exercise price
$
12.34

$
9.03

Weighted average fair value
$
8.01

$
6.06

Aggregate intrinsic value (in thousands)
$
76,923

$
65,271



The following table summarizes RSU and restricted stock award activity during the nine months ended September 30, 2019:

 
Number of Shares
Weighted Average Grant Date Fair Value per Share
Outstanding January 1, 2019
76,000

$
18.70

Granted
11,000

20.32

Forfeited
(60,500
)
19.74

Vested/released
(7,000
)
19.47

Outstanding September 30, 2019
19,500

16.13



Equity-based compensation expense is summarized below (in thousands):

 
Three Months Ended
 
Nine Months Ended
 
September 30,
September 30,
 
September 30,
September 30,
 
2019
2018
 
2019
2018
Cost of sales
$
65

$
68

 
$
172

$
172

Research and development
897

1,476

 
3,226

3,926

Sales, general and administrative
2,169

1,921

 
6,011

8,378

 
$
3,131

$
3,465

 
$
9,409

$
12,476



For each of the three months ended September 30, 2019 and 2018, $0.1 million of share-based compensation cost was capitalized to inventory or inventory transferred to property and equipment (also referred to as instruments). During the nine months ended September 30, 2019 and 2018, $0.3 million and $0.4 million, respectively, of share-based compensation cost was capitalized to inventory or inventory transferred to property and equipment (also referred to as instruments).

As of September 30, 2019, unrecognized equity-based compensation expense related to unvested stock options and unvested RSUs was $27.1 million and $0.2 million, respectively. This is expected to be recognized over the years 2019 through 2024.

Included in the above-noted stock option grants and stock compensation expense are performance-based stock options which vest only upon the achievement of certain targets. Performance-based options are generally granted at-the-money, contingently vest over a period of 1 to 2 years, depending on the nature of the performance goal, and have contractual lives of 10 years. These options were valued in the same manner as the time-based options, with the assumption that performance goals will be achieved. The inputs for expected volatility, expected dividends, and risk-free rate used in estimating those options’ fair value are the same as the time-based options issued under the plan. The expected term for performance-based options granted in 2018 is 5 to 6 years. However, the Company only recognizes stock compensation expense to the extent that the targets are determined to be probable of being achieved, which triggers the vesting of the performance options. In 2018, the Company granted 225,000 performance based-options to certain employees, of which 125,000 were outstanding as of September 30, 2019. The Company recognized $0.1 million of stock compensation expense for the nine months ended September 30, 2019 for performance-based stock options.